API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204382
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-cuts-price-of-cardiovascular-drug-cidmus/articleshow/97091194.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-heart-drug-price-may-fall-by-60-on-generic-rollouts/articleshow/97102183.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-reserves-order-on-natcos-plea-over-patent-for-novartis-drug/articleshow/96920043.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.fiercepharma.com/pharma/novartis-pays-245m-settle-exforge-generic-pay-delay-lawsuits
https://health.economictimes.indiatimes.com/news/pharma/top-novartis-cardiac-drug-to-go-off-patent/95952280
https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html
https://www.raps.org/news-and-articles/news-articles/2022/10/prompted-by-recent-recalls-regulators-scramble-to
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210596
https://www.fiercepharma.com/pharma/novartis-takes-entresto-generic-fight-fda-again-after-similar-appeal-flopped-april
https://www.fiercepharma.com/pharma-asia/biocon-viatris-insulin-biosimilar-astrazeneca-china-performance-huahai-fda-warning-lift
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-restrains-generic-pharma-firms-from-making-selling-patent-drug-of-novartis/articleshow/87483290.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214102
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204038
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204038
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201618
https://www.newswire.ca/news-releases/advisory-multiple-lots-of-irbesartan-losartan-and-valsartan-drugs-recalled-due-to-azido-impurity-824128492.html
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php
https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75703r-eng.php
https://endpts.com/novartis-whiffs-on-entresto-study-after-heart-attacks-but-that-doesnt-mean-its-going-down-quietly/
https://www.healio.com/news/cardiology/20210517/sacubitrilvalsartan-not-superior-to-valsartan-alone-in-advanced-hfref-life#:~:text=In%20patients%20with%20advanced%20HF,results%20of%20the%20LIFE%20trial.
https://www.fiercepharma.com/pharma/novartis-entresto-falls-short-post-heart-attack-trial
https://www.fiercepharma.com/marketing/where-do-you-stand-fda-reviewers-argue-for-novartis-entresto-committee-meeting-file
https://www.nytimes.com/2020/07/01/business/Novartis-kickbacks-diabetes-heart-drugs.html
https://www.news-medical.net/news/20200511/AI-VIVO-seeks-pharma-biotech-collaboration-partners-to-advance-drug-candidates-for-COVID-19.aspx
http://www.pmlive.com/pharma_news/cosentyx,_entresto_drive_topline_growth_for_novartis_in_q4_1323659
https://www.fiercepharma.com/manufacturing/year-ahead-fpm-story
https://www.business-standard.com/article/pti-stories/sun-pharma-gets-partial-relief-from-us-court-in-litigation-involving-three-generic-drugs-119120200818_1.html
https://www.prnewswire.com/news-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref-300959592.html
https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure
https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mylan-to-invest-1-billion-in-india-on-capex-in-6-years/articleshow/71358699.cms
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-entresto-207620-sacubitril-and-valsartantablets-24-mg26-mg-49-mg51-mg-97-mg103-mg-1569473893.pdf
https://www.cnbc.com/2019/09/13/fda-finds-impurity-in-heartburn-medicine-zantac-that-could-cause-cancer.html
https://www.raps.org/news-and-articles/news-articles/2019/9/ema-begins-testing-heartburn-medicines-for-carcino
https://www.nbcnews.com/health/health-care/u-s-officials-worried-about-chinese-control-american-drug-supply-n1052376?cid=public-rss_20190912
https://www.fiercepharma.com/manufacturing/aurobindo-recalls-mislabeled-statin-tablets-off-u-s-market
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205347
https://www.reuters.com/article/us-fda-valsartan/fda-says-widening-probe-on-generic-drug-impurities-idUSKCN1VI1RH
https://www.in-pharmatechnologist.com/Article/2019/08/14/The-sartan-saga-Recapping-the-recalls
https://www.raps.org/news-and-articles/news-articles/2019/8/ndea-and-ndma-impurities-another-indian-manufactu
http://www.pharmafile.com/news/525299/novartis-entresto-falls-short-phase-3-heart-failure-preserved-ejection-fraction
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-fda-finds-significant-violations-at-indias-strides-plant/articleshow/70256012.cms
https://www.raps.org/news-and-articles/news-articles/2019/7/manufacturing-concerns-lead-fda-to-pull-31-apotex?feed=Regulatory-Focus
https://www.fiercepharma.com/manufacturing/aurobindo-gets-warning-letter-over-valsartan-recall-mess
https://www.raps.org/news-and-articles/news-articles/2019/7/fda-sends-warning-letters-to-aurobindo-api-repack?feed=Regulatory-Focus
https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms
https://www.fiercepharma.com/manufacturing/pharmacy-takes-fda-to-task-citizen-petition-over-tainted-valsartan